People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ankasa Regenerative Therapeutics, Inc. | — | Biotechnology | Series A | $15.5M | $192.5M | 2015 |
Douglas J. Downs at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas J. Downs on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin J. Kinsella | 1 | 2 |
| Tighe J. Reardon | 1 | 2 |
| Sanford J. Madigan | 1 | 1 |
| Andre J. Kobelt, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.